Aurobindo Gets US FDA Approval For Bisoprolol Tablets And Amoxicillin Oral Suspension (Nasdaq)
(RTTNews) - Aurobindo Pharma announced that the company obtained two more approvals from US FDA for its Bisoprolol of 5 mg, 10 mg and Amoxicillin oral suspension of 200-mg/5 ml and 400-mg/5 ml.

FDA drug approval at lowest rate (The Star-Ledger)
As the American pharmaceutical industry grapples with layoffs and spending cuts, newly released statistics show drugmakers continue to struggle with the discovery of blockbuster medicines.

DURECT Starts Phase II Dosing For TRANSDUR(TM)-Bupivacaine (DUR-843) (Medical News Today)
DURECT Corporation (Nasdaq: DRRX) today announced that we have started Phase II dosing in the U.S. under an FDA-accepted Investigational New Drug (IND) application for TRANSDUR(TM)-Bupivacaine (DUR-843), a transdermal pain patch for patients suffering from Post-Herpetic Neuralgia (post-shingles pain or PHN). [click link for full article]